358 related articles for article (PubMed ID: 30862773)
1. Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms.
Chen X; Zhang X; Pan J
Med Sci Monit; 2019 Mar; 25():1886-1893. PubMed ID: 30862773
[TBL] [Abstract][Full Text] [Related]
2. Human β-Defensin-2 Improves Hyperoxia-Induced Lung Structural and Functional Injury in Neonatal Rats.
Sun Y; Chen C; Di T; Yang J; Wang K; Zhu Y; Zhu R; Zhou A; Qian Y
Med Sci Monit; 2019 Aug; 25():6074-6084. PubMed ID: 31411185
[TBL] [Abstract][Full Text] [Related]
3. Montelukast improves bronchopulmonary dysplasia by inhibiting epithelial‑mesenchymal transition via inactivating the TGF‑β1/Smads signaling pathway.
Chen X; Peng W; Zhou R; Zhang Z; Xu J
Mol Med Rep; 2020 Sep; 22(3):2564-2572. PubMed ID: 32705209
[TBL] [Abstract][Full Text] [Related]
4. Treatment with Geranylgeranylacetone Induces Heat Shock Protein 70 and Attenuates Neonatal Hyperoxic Lung Injury in a Model of Bronchopulmonary Dysplasia.
Tokuriki S; Igarashi A; Okuno T; Ohta G; Naiki H; Ohshima Y
Lung; 2017 Aug; 195(4):469-476. PubMed ID: 28447205
[TBL] [Abstract][Full Text] [Related]
5. Does Chrysin prevent severe lung damage in Hyperoxia-Induced lung injury Model?
Ozdemir R; Gokce IK; Taslidere AC; Tanbek K; Gul CC; Sandal S; Turgut H; Kaya H; Aslan M
Int Immunopharmacol; 2021 Oct; 99():108033. PubMed ID: 34343938
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA Rian protects against experimental bronchopulmonary dysplasia by sponging miR-421.
Tao X; Fang Y; Huo C
Exp Ther Med; 2021 Jul; 22(1):781. PubMed ID: 34055080
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
[TBL] [Abstract][Full Text] [Related]
8. Montelukast attenuates interleukin IL-1β-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2).
Li Z; Wang J; Ma Y
Bioengineered; 2021 Dec; 12(1):8476-8484. PubMed ID: 34565285
[TBL] [Abstract][Full Text] [Related]
9. Colchicine protects against hyperoxic lung injury in neonatal rats.
Ozdemir R; Yurttutan S; Talim B; Uysal B; Erdeve O; Oguz SS; Dilmen U
Neonatology; 2012; 102(4):265-9. PubMed ID: 22922655
[TBL] [Abstract][Full Text] [Related]
10. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
11. Lysine demethylase KDM3A alleviates hyperoxia-induced bronchopulmonary dysplasia in mice by promoting ETS1 expression.
Yang M; Chen Y; Huang X; Shen F; Meng Y
Exp Cell Res; 2024 Feb; 435(2):113945. PubMed ID: 38286256
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of lncRNA H19 in Regulating Pulmonary Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia Newborn Mice.
Zhang L; Wang P; Shen Y; Huang T; Hu X; Yu W
Am J Perinatol; 2022 Jul; 39(10):1089-1096. PubMed ID: 33285606
[TBL] [Abstract][Full Text] [Related]
13. [Effect of rhubarb on neonatal rats with bronchopulmonary dysplasia induced by hyperoxia].
Yin LL; Ye ZZ; Tang LJ; Guo L; Huang WM
Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):410-415. PubMed ID: 29764580
[TBL] [Abstract][Full Text] [Related]
14. Cell Division Cycle 2 Protects Neonatal Rats Against Hyperoxia-Induced Bronchopulmonary Dysplasia.
Li Z; Chen Y; Li W; Yan F
Yonsei Med J; 2020 Aug; 61(8):679-688. PubMed ID: 32734731
[TBL] [Abstract][Full Text] [Related]
15. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
16. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
17. Quercetin attenuates the hyperoxic lung injury in neonatal mice: Implications for Bronchopulmonary dysplasia (BPD).
Maturu P; Wei-Liang Y; Androutsopoulos VP; Jiang W; Wang L; Tsatsakis AM; Couroucli XI
Food Chem Toxicol; 2018 Apr; 114():23-33. PubMed ID: 29432836
[TBL] [Abstract][Full Text] [Related]
18. Nesfatin-1 alleviates hyperoxia-induced bronchopulmonary dysplasia (BPD) via the nuclear factor-κB (NF-κB) p65 signaling pathway.
Zhang L; Zhuo Z; Chen L; Liu J; Huang J; Deng J; Lu W; Jiang X
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23680. PubMed ID: 38511245
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
20. BCL6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse.
Chen D; Zhao HM; Deng XH; Li SP; Zhou MH; Wu YX; Tong Y; Yu RQ; Pang QF
Exp Lung Res; 2024; 50(1):25-41. PubMed ID: 38419581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
